Emerging Therapeutic Targets and Drug Delivery Approaches in IBD
- 1st Edition, Volume 101 - November 13, 2024
- Editor: Florin Selaru
- Language: English
- Hardback ISBN:9 7 8 - 0 - 4 4 3 - 3 1 3 5 8 - 5
- eBook ISBN:9 7 8 - 0 - 4 4 3 - 3 1 3 5 9 - 2
Emerging Therapeutic Targets and Drug Delivery Approaches in IBD, Volume 101 in this ongoing series, highlights new advances, with this volume presenting interesting chapte… Read more
Emerging Therapeutic Targets and Drug Delivery Approaches in IBD, Volume 101 in this ongoing series, highlights new advances, with this volume presenting interesting chapters on timely topics, including Fibrosis in IBD – AXL as a Promising Therapeutic Target, Developing a pathway to test anti-fibrotic drugs in Crohn’s disease, Emerging therapeutics for the management of intestinal fibrosis and strictures, GCPII for IBD, Fistulas/stem cell products for IBD/Crohn’s, The landscape of new therapeutic opportunities for IBD, TL1A : A Model For The Use Of Precision Medicine For The Treatment of Crohn’s Disease and Ulcerative Colitis, Dectin-1 as a therapeutic target for IBD, and more.
Additional sections cover BRD4 as an Emerging Epigenetic Therapeutic Target for Inflammatory Bowel Diseases, Scripps - S1P, The potential of targeting TREM-1 in Inflammatory Bowel Disease, and Microbiome therapies.
Additional sections cover BRD4 as an Emerging Epigenetic Therapeutic Target for Inflammatory Bowel Diseases, Scripps - S1P, The potential of targeting TREM-1 in Inflammatory Bowel Disease, and Microbiome therapies.
- Provides the latest information on emerging therapeutic targets and drug research
- Offers outstanding and original reviews on a range of emerging therapeutic targets and drug research topics
- Serves as an indispensable reference for researchers and students alike
Provides invaluable information on the fast-moving field of emerging therapeutic targets and drug research that includes outstanding original reviews on a variety of topics
1. Fibrosis in IBD – AXL as a Promising Therapeutic Target
Calen Steiner and P Higgins
2. Developing a pathway to test anti-fibrotic drugs in Crohn’s disease
Florian Rieder
3. Emerging therapeutics for the management of intestinal fibrosis and strictures
Laura Ensign and Florin M. Selaru
4. GCPII for IBD
Diane E. Peters
5. Fistulas/stem cell products for IBD/Crohn’s
Hai-Quan Mao
6. The landscape of new therapeutic opportunities for IBD
Andres Hurtado-Lorenzo and Jennifer L. Swantek
7. TL1A : A Model For The Use Of Precision Medicine For The Treatment of Crohn’s Disease and Ulcerative Colitis
Stephan Targan
8. Dectin-1 as a therapeutic target for IBD
Xiaolei Zhu
9. BRD4 as an Emerging Epigenetic Therapeutic Target for Inflammatory Bowel Diseases
Jia Zhou
10. Scripps - S1P
Hugh Rosen
11. The potential of targeting TREM-1 in Inflammatory Bowel Disease
Marc Derive
12. Microbiome therapies
Christopher Burton Ford
Calen Steiner and P Higgins
2. Developing a pathway to test anti-fibrotic drugs in Crohn’s disease
Florian Rieder
3. Emerging therapeutics for the management of intestinal fibrosis and strictures
Laura Ensign and Florin M. Selaru
4. GCPII for IBD
Diane E. Peters
5. Fistulas/stem cell products for IBD/Crohn’s
Hai-Quan Mao
6. The landscape of new therapeutic opportunities for IBD
Andres Hurtado-Lorenzo and Jennifer L. Swantek
7. TL1A : A Model For The Use Of Precision Medicine For The Treatment of Crohn’s Disease and Ulcerative Colitis
Stephan Targan
8. Dectin-1 as a therapeutic target for IBD
Xiaolei Zhu
9. BRD4 as an Emerging Epigenetic Therapeutic Target for Inflammatory Bowel Diseases
Jia Zhou
10. Scripps - S1P
Hugh Rosen
11. The potential of targeting TREM-1 in Inflammatory Bowel Disease
Marc Derive
12. Microbiome therapies
Christopher Burton Ford
- Edition: 1
- Volume: 101
- Published: November 13, 2024
- Language: English
Read Emerging Therapeutic Targets and Drug Delivery Approaches in IBD on ScienceDirect